Fibroblast–tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways
Publication information:
Zervantonakis I, Poskus M, Scott A, Selfors L, Lin J-R, Dillon D, Pathania S, Sorger P, Mills G, Brugge J. Fibroblast–tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways. Proceedings of the National Academy of Sciences. 2020;117(28):16500–16508.